Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Acquired hemophilia A (AHA) is a rare bleeding disorder (1.4 per million inhabitants per year) caused by neutralizing antibodies against factor VIII. Although uncommon, these autoantibodies can cause a high rate of morbidity and mortality. Several conditions are linked with AHA; based on an EACH2 study, 3.8% of AHA could be connected to infection....
Alternative Titles
Full title
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f63743adef744e0288e029e79621673e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f63743adef744e0288e029e79621673e
Other Identifiers
ISSN
2076-393X
E-ISSN
2076-393X
DOI
10.3390/vaccines12070709
